Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NX1 Announcements
Significant Milestone - First Patient…
NX1
NEXALIS THERAPEUTICS LTD
Market sensitive
Significant Milestone - First Patient Screened IRX-211 Ph2
Date and time
20 April 2026 at 7:59 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
NX1 announcement history
Recent NX1 announcements
Jun26 Appendix 4C Cash Flow Report
Jun26 Quarterly Activities Report
Change in substantial holding
Change of Director's Interest Notice - Sean Williams
Change of Director's Interest Notice - Darryl Davies
Notification of cessation of securities - NX1